The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / B•••••••••

A•••••• Capital Partners Invests In B•••••••••

Platform acquisitionannouncedannouncement date unknownFact
What happened
Target
B•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
NY, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • A•••••• C•••••• M••••••••• L•Sponsorconfirmed
    “A•••••• Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies, announced today its majority investment in B••••••••• (“BioIVT”) in a recapitalization of the company.”
Advisory side
  • K••••••• • E•••• L••Buy-side adviserconfirmed
    “A•••••• was advised by K••••••• & E••••.”
Side not stated
Evidence
“A•••••• Capital Partners Invests In B•••••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 18, 2026
A•••••• Capital Partners Invests In B••••••••• | Private Equity Intelligence | DFX